Skip to content
Search

Latest Stories

Follow Us:
Top Stories

U.S. Healthcare in 2025: Chaos, Costs, and Controversy Without Real Progress

Opinion

U.S. Healthcare in 2025: Chaos, Costs, and Controversy Without Real Progress
a person wearing a blue shirt with a white circle on it
Photo by Nappy on Unsplash

The year 2025 has been one of the most turbulent years in modern U.S. healthcare. The headlines were explosive, the rhetoric dramatic, and the controversies nonstop. Yet for all the hoopla and upheaval, the medical care Americans receive now, month in and month out, looks no better than what they experienced on January 1 — but far more expensive.

Here are five areas of healthcare that generated chaos, confusion, and conflict in 2025 without meaningful improvement.


1. Political Chaos: Turning Science Into A Battleground

No aspect of healthcare saw more volatility in 2025 than in the political arena. The tone was set in January when President Trump returned to office and began reshaping federal health agencies with unprecedented speed.

Within days, he issued a record flurry of executive orders targeting the Affordable Care Act, Medicaid waivers, Medicare Advantage oversight, prior-authorization rules, and federal nutrition standards.

He replaced long-entrenched leaders at HHS, NIH, CDC, and FDA with political outsiders, many of whose views on vaccines, chronic disease, and scientific evidence diverged sharply from the career experts they superseded. The nomination of RFK Jr. to lead HHS became a flashpoint. His reluctance to confront the measles outbreak in Texas, combined with mixed messaging on vaccine policy, has deepened public health concerns.

Since then, senior scientists and leaders in federal healthcare agencies have resigned, with key programs becoming stalled and career staff reporting political interference in decisions that previously rested on data and expert consensus.

2. Economic Crisis: Costs Soar As Coverage Becomes More Fragile

Beneath the political theatrics of 2025 lay a sobering reality: Americans will once again pay far more for healthcare next year than the year before. And for many, the financial protections that once softened those increases are disappearing.

Insurers on the Affordable Care Act (ACA) marketplace requested median premium hikes of 18% for 2026, the steepest jump since 2018 and well above this year’s 7% hike. If Congress fails to extend the enhanced ACA subsidies, families who once paid affordable monthly premiums will see their costs double or even triple.

The broader economic picture makes these pressures unavoidable. The United States is now spending $5.6 trillion annually on healthcare, with costs projected to rise 7.1% this year, far outpacing economic growth.

3. Regulatory Confusion: Agencies Rebooted, But Improved Health Still Distant

This year shook the foundations of America’s public-health architecture and left yawning gaps where trust, clarity, and expert oversight once stood. Politics has replaced science as the primary driver of healthcare policy.

The Centers for Disease Control and Prevention lost its director just weeks after her confirmation. Within days, top-level scientists and center heads resigned en masse, citing political interference and a collapse of scientific independence. At year’s end, there still is no permanent CDC head.

Federal health recommendations — particularly those issued by agencies and advisory committees — have shifted away from rigorous, peer-driven review and toward decisions increasingly shaped by anecdote and ideology.

Meanwhile, the administration’s sweeping “health-freedom agenda” (under the banner Make America Healthy Again) has identified food packaging, additives, school-lunch standards and “ultra-processed” diets as public-health priorities. But the proposals to improve nutrition remain largely unformed, as the likelihood of meaningful improvements fade in the face of pushback from the food industry.

What remains at year’s end is a set of agencies still functioning, but with public trust weakened and no clear path to rebuilding it.

4. Technological Contradiction: AI Leapt Forward While Medicine Stood Still

No field generated more excitement, or exposed more contradictions, in 2025 than generative artificial intelligence.

In the broader economy, GenAI models transformed finance, logistics, law, retail and customer service. New large language models, including GPT-5, DeepSeek and Gemini 3, demonstrated near-expert performance on clinical reasoning, interpretation of complex symptoms and risk prediction. And with the emergence of Artificial General Intelligence (AGI), Americans are increasingly relying on large language models when they have medical questions. In polling I conducted this fall, 77% of patients and 63% of healthcare professionals reported using a generative-AI tool in the past three months for health-related information or decision support.

Yet inside traditional medicine, progress remains stalled. Clinicians continue to be encouraged to use AI for administrative shortcuts (coding, charting, prior authorization claims) but national specialty organizations haven’t pushed them to use GenAI for diagnosing disease, reducing medical errors or improving clinical outcomes.

Meanwhile, medical schools still teach pre-AI workflows, even as medical students and residents turn to GenAI for clinical knowledge and case analysis. The divide between institutional practice and the behaviors of patients and the next generation of physicians is expanding at an accelerating pace.

5. Cultural Conflict: A Growing Divide Between The Public And The Profession

If 2025 revealed anything about American healthcare, it was a widening cultural rift: between younger patients and medical professionals, and between science and public belief.

This rift is felt particularly among Gen Z and Millennials, generations that grew up online, are accustomed to second-screen verification and skeptical of traditional authority. Younger Americans expect shared decision-making, transparency and digital-first convenience — expectations medicine failed to fulfill in 2025.

At the same time, disinformation and political rhetoric seeped deeper into public life. Social media spread half-truths faster than public-health leaders could correct them. Vaccine skepticism rose thanks to political disinformation. Basic nutritional science became partisan, too. And the public’s confusion intensified.

What 2025 Reveals About the Road Ahead

By year’s end, one truth became impossible to ignore: despite unprecedented political turmoil, economic instability, scientific breakthroughs and cultural upheaval, the health of our nation failed to improve.

The incentives driving the system, the chronic diseases afflicting the population and the unaffordability confronting families all persist as we enter 2026. At the same time, as generative AI transforms nearly every other sector of the economy, the fax machine remains the most common method physicians use to exchange vital medical information.

The biggest question for 2026 is whether the pressures now bearing down on the system — economic, political, technological, cultural — will finally force American medicine to change, or whether the year ahead will look much like 2025 did.

Robert Pearl, the author of “ChatGPT, MD,” teaches at both the Stanford University School of Medicine and the Stanford Graduate School of Business. He is a former CEO of The Permanente Medical Group.


Read More

The ACA’s Missing Mandate: Why Costs Keep Rising

Repealing the ACA’s individual mandate destabilized insurance markets, drove premiums higher, and left families paying the price.

Getty Images

The ACA’s Missing Mandate: Why Costs Keep Rising

By repealing the Affordable Care Act’s individual mandate, policymakers allowed healthy Americans to walk away—leaving insurers with risk pools dominated by those most likely to need care. The result was inevitable: premiums soared, markets destabilized, and families were left paying the price.

When Congress passed the ACA, its most controversial feature was the individual mandate—the requirement that all Americans carry health insurance or pay a penalty. Critics called it coercion. In reality, it was the glue holding the system together.

Keep ReadingShow less
A stethoscope, calculator, pills, and cash.

As ACA subsidies expire and Medicaid rolls shrink, millions could face higher premiums or lose coverage, reigniting a national healthcare debate.

Getty Images, athima tongloom

How Expiring Subsidies and Medicaid Cuts Could Reshape U.S. Access to Care

Current Issue

In the coming year, millions of Americans could see their health insurance premiums rise, or lose coverage entirely, as key federal supports for affordable care are set to expire. The American Rescue Plan Act of 2021 (ARPA) subsidies under the Affordable Care Act (ACA) marketplace, which were later extended by the Inflation Reduction Act, are scheduled to expire at the end of 2025. According to one analysis, if these enhanced subsidies expire, premiums on average could increase by 25-100 percent. At the same time, several states are reducing Medicaid rolls following the end of the pandemic-era continuous coverage requirement. Over 25 million people had been disenrolled from Medicaid and CHIP during this process in 2024. Together, these changes could redefine U.S. healthcare access, reigniting debates about public health and fiscal restraint.

Background

The ACA, passed in 2010, aimed to make health insurance more accessible for millions of uninsured Americans by expanding Medicaid eligibility and creating subsidized plans under the premium tax credit. The ARPA of 2021 significantly increased those marketplace subsidies, eliminating the 400% of poverty threshold for eligibility and reducing the percentage of income that enrollees must pay in premiums. As a result, the number of people eligible for marketplace subsidies increased from 18.1 million to 21.8 million from 2020-2021. Meanwhile, pandemic policies prevented states from disenrolling almost all Medicaid and CHIP enrollees for over three years. When this continuous coverage requirement ended in April of 2023, states began to reevaluate the eligibility of tens of millions of people. The expiration of ARPA temporary subsidies combined with the end of continuous Medicaid coverage set the stage for a contentious healthcare market next year.

Keep ReadingShow less
University Roundtable Puts Latino Mental Health Front and Center

woman holds "Hablo Espanol" button

Picture Provided

University Roundtable Puts Latino Mental Health Front and Center

“Keep it to yourself. Push it down. Don’t say anything.” That is how Isis Lara Fernandez was taught to live with her status as an undocumented immigrant in the United States.

At 6-years-old, Lara Fernandez fled to the U.S. with her mother and siblings to escape domestic violence in Honduras. From that point forward, Lara Fernandez navigated life with a persistent fear that her secret could be discovered at any point in time.

Keep ReadingShow less
The Health Care Debate & Feldstein’s Fix
black and gray stethoscope

The Health Care Debate & Feldstein’s Fix

Serving in Congress during the implementation of President Barack Obama’s Affordable Care Act, Republicans embraced the position of “repeal and replace.” Repeal the ACA, but replace it with what? The debate is front-and-center again, though the ground has shifted some. There is more support for the ACA. Even some Republicans are looking to temporarily extend COVID-era subsidies for ACA health plans. Other Republicans want Health Savings Accounts, so more money goes to individuals instead of insurance companies. Democratic leadership seeks an approach temporarily extending the expanded premium subsidies, during which the entire approach to health care can be rethought.

The late economist Martin Feldstein had the fix: Martin Feldstein proposed a voucher system in which everyone could purchase a health insurance plan covering health care expenses exceeding 15% of their income. This could be combined with HSAs if they prove popular with the public.

Keep ReadingShow less